0,590€
-16,31%
Echtzeit-Aktienkurs MESOBLAST LTD.
Bid:
Ask:
Echtzeit-Chart der MESOBLAST LTD. Aktie
Börsenkurse MESOBLAST LTD.
Echtzeit Euro | - | - | - | - | 0,695€ | -1,42% |
gettex | - | - | - | - | 0,693€ | -4,41% |
Tradegate | - | - | - | - | 0,695€ | -4,14% |
Börse Stuttgart | - | - | - | - | 0,590€ | -16,31% |
Profil der MESOBLAST LTD. Aktie
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.